Beranda › Kanker Paru
Uji klinis Kanker Paru yang merekrut di AS
348 studi untuk Kanker Paru merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX78 studi
- Boston, MA62 studi
- New York City, NY60 studi
- Los Angeles, CA45 studi
- Washington, DC41 studi
- Arlington, VA41 studi
- Chicago, IL41 studi
- Nashville, TN40 studi
- Baltimore, MD40 studi
- St. Louis, MO39 studi
- Columbus, OH37 studi
- Philadelphia, PA36 studi
- Seattle, WA33 studi
- Durham, NC32 studi
- Atlanta, GA29 studi
- Tampa, FL29 studi
- Dallas, TX27 studi
- San Antonio, TX26 studi
- Cleveland, OH26 studi
- Portland, OR26 studi
- Baldwin Park, CA24 studi
- San Francisco, CA23 studi
- San Diego, CA23 studi
- Pittsburgh, PA23 studi
- Ann Arbor, MI23 studi
- Edison, NJ23 studi
- New Haven, CT22 studi
- Sacramento, CA22 studi
- Queens, NY22 studi
- Milwaukee, WI21 studi
- Salt Lake City, UT21 studi
- Orlando, FL21 studi
- Minneapolis, MN20 studi
- Detroit, MI20 studi
- Rochester, MN20 studi
- Miami, FL20 studi
- Aurora, CO19 studi
- Evanston, IL19 studi
- Oklahoma City, OK19 studi
- Kansas City, MO19 studi
Berdasarkan negara bagian
- Alabama16 studi
- Alaska7 studi
- Arizona34 studi
- Arkansas19 studi
- California112 studi
- Colorado38 studi
- Connecticut30 studi
- Delaware11 studi
- Distrik Columbia27 studi
- Florida76 studi
- Georgia40 studi
- Hawaii8 studi
- Idaho11 studi
- Illinois62 studi
- Indiana25 studi
- Iowa19 studi
- Kansas21 studi
- Kentucky26 studi
- Louisiana16 studi
- Maine12 studi
- Maryland56 studi
- Massachusetts75 studi
- Michigan44 studi
- Minnesota42 studi
- Mississippi14 studi
- Missouri44 studi
- Montana14 studi
- Nebraska19 studi
- Nevada11 studi
- New Hampshire12 studi
- New Jersey42 studi
- New Mexico15 studi
- New York93 studi
- North Carolina50 studi
- North Dakota15 studi
- Ohio68 studi
- Oklahoma20 studi
- Oregon31 studi
- Pennsylvania57 studi
- Rhode Island6 studi
- South Carolina19 studi
- South Dakota15 studi
- Tennessee58 studi
- Texas101 studi
- Utah25 studi
- Vermont7 studi
- Virginia58 studi
- Washington43 studi
- West Virginia11 studi
- Wisconsin31 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04267848Evaluation for NCI Surgery Branch Clinical Research Protocols
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT00001823Prospective Multiomic Analysis in Small-Cell Lung Cancer
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07795411Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
Menerima pesertaStudi observasional
Usia 2 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT00242723Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04991025Smoking Cessation CM for Veterans With or at Risk for Cancer
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06432985The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Menerima pesertaFase 1/2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04585750Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Menerima pesertaStudi observasional
Usia 2 hingga 100 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT01950572Distance-Based Exercise to Preserve Function and Prevent Disability
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07059884Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Menerima pesertaFase 1
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06885697Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT06780098Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Menerima pesertaStudi observasional
Usia 3 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT01441089Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06918132A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07286149A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06172478Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Menerima pesertaFase 3
Usia 70 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06096844Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT04181060Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06625775Empathic Communication Skills (ECS) Training
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05456841Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06498635The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07285044Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06765109Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06881784DK222 Study at Hopkins
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07140315Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.